21 June 2021Core One (COOL.C) subsidiary begins development of psychedelic drug formulation…Piers Eaton COOL.C Core One Labs’ (COOL.C) wholly-owned subsidiary, Akome Biotech, has begun the development of a next-generation psychedelic drug formulation for the purpose of mitigating neurological damage that results from ischemic…